nodes	percent_of_prediction	percent_of_DWPC	metapath
Tetrahydrobiopterin—TH—prostate cancer	0.321	0.575	CbGaD
Tetrahydrobiopterin—NOS3—prostate cancer	0.186	0.333	CbGaD
Tetrahydrobiopterin—NOS3—Doxorubicin—prostate cancer	0.146	0.846	CbGbCtD
Tetrahydrobiopterin—PTGS2—prostate cancer	0.0515	0.0922	CbGaD
Tetrahydrobiopterin—PTGS2—Etoposide—prostate cancer	0.0264	0.154	CbGbCtD
Tetrahydrobiopterin—NOS3—penis—prostate cancer	0.0108	0.339	CbGeAlD
Tetrahydrobiopterin—PAH—renal system—prostate cancer	0.00323	0.101	CbGeAlD
Tetrahydrobiopterin—TH—prostate gland—prostate cancer	0.00288	0.09	CbGeAlD
Tetrahydrobiopterin—NOS3—prostate gland—prostate cancer	0.00259	0.081	CbGeAlD
Tetrahydrobiopterin—TH—renal system—prostate cancer	0.00196	0.0613	CbGeAlD
Tetrahydrobiopterin—NOS3—epithelium—prostate cancer	0.0019	0.0595	CbGeAlD
Tetrahydrobiopterin—NOS3—renal system—prostate cancer	0.00176	0.0552	CbGeAlD
Tetrahydrobiopterin—NOS3—testis—prostate cancer	0.00114	0.0357	CbGeAlD
Tetrahydrobiopterin—TH—lymph node—prostate cancer	0.000919	0.0287	CbGeAlD
Tetrahydrobiopterin—NOS3—lymph node—prostate cancer	0.000827	0.0259	CbGeAlD
Tetrahydrobiopterin—PTGS2—prostate gland—prostate cancer	0.000821	0.0257	CbGeAlD
Tetrahydrobiopterin—PTGS2—seminal vesicle—prostate cancer	0.000694	0.0217	CbGeAlD
Tetrahydrobiopterin—PTGS2—epithelium—prostate cancer	0.000603	0.0189	CbGeAlD
Tetrahydrobiopterin—PTGS2—renal system—prostate cancer	0.000559	0.0175	CbGeAlD
Tetrahydrobiopterin—PTGS2—urethra—prostate cancer	0.00055	0.0172	CbGeAlD
Tetrahydrobiopterin—PTGS2—bone marrow—prostate cancer	0.000423	0.0132	CbGeAlD
Tetrahydrobiopterin—PTGS2—lymph node—prostate cancer	0.000262	0.0082	CbGeAlD
Tetrahydrobiopterin—Dyspepsia—Conjugated Estrogens—prostate cancer	0.000158	0.00142	CcSEcCtD
Tetrahydrobiopterin—Irritability—Prednisone—prostate cancer	0.000155	0.0014	CcSEcCtD
Tetrahydrobiopterin—Gastrointestinal disorder—Conjugated Estrogens—prostate cancer	0.000155	0.0014	CcSEcCtD
Tetrahydrobiopterin—Nausea—Bicalutamide—prostate cancer	0.000155	0.00139	CcSEcCtD
Tetrahydrobiopterin—Cough—Estradiol—prostate cancer	0.000153	0.00138	CcSEcCtD
Tetrahydrobiopterin—Neutropenia—Docetaxel—prostate cancer	0.000152	0.00137	CcSEcCtD
Tetrahydrobiopterin—Diarrhoea—Ethinyl Estradiol—prostate cancer	0.000151	0.00136	CcSEcCtD
Tetrahydrobiopterin—Arthralgia—Estradiol—prostate cancer	0.00015	0.00135	CcSEcCtD
Tetrahydrobiopterin—Unspecified disorder of skin and subcutaneous tissue—Estradiol—prostate cancer	0.000149	0.00134	CcSEcCtD
Tetrahydrobiopterin—Gastrointestinal pain—Goserelin—prostate cancer	0.000148	0.00133	CcSEcCtD
Tetrahydrobiopterin—Neutropenia—Capecitabine—prostate cancer	0.000147	0.00133	CcSEcCtD
Tetrahydrobiopterin—Gastrointestinal pain—Conjugated Estrogens—prostate cancer	0.000147	0.00132	CcSEcCtD
Tetrahydrobiopterin—Upper respiratory tract infection—Capecitabine—prostate cancer	0.000146	0.00132	CcSEcCtD
Tetrahydrobiopterin—Dizziness—Ethinyl Estradiol—prostate cancer	0.000145	0.00131	CcSEcCtD
Tetrahydrobiopterin—Infestation NOS—Docetaxel—prostate cancer	0.000145	0.00131	CcSEcCtD
Tetrahydrobiopterin—Infestation—Docetaxel—prostate cancer	0.000145	0.00131	CcSEcCtD
Tetrahydrobiopterin—Anaphylactic shock—Estradiol—prostate cancer	0.000144	0.00129	CcSEcCtD
Tetrahydrobiopterin—Abdominal pain—Goserelin—prostate cancer	0.000143	0.00129	CcSEcCtD
Tetrahydrobiopterin—Body temperature increased—Goserelin—prostate cancer	0.000143	0.00129	CcSEcCtD
Tetrahydrobiopterin—Cough—Mitoxantrone—prostate cancer	0.000143	0.00129	CcSEcCtD
Tetrahydrobiopterin—Acute coronary syndrome—Docetaxel—prostate cancer	0.000143	0.00129	CcSEcCtD
Tetrahydrobiopterin—Infection—Estradiol—prostate cancer	0.000143	0.00128	CcSEcCtD
Tetrahydrobiopterin—Myocardial infarction—Docetaxel—prostate cancer	0.000142	0.00128	CcSEcCtD
Tetrahydrobiopterin—Convulsion—Mitoxantrone—prostate cancer	0.000142	0.00128	CcSEcCtD
Tetrahydrobiopterin—Abdominal pain—Conjugated Estrogens—prostate cancer	0.000142	0.00128	CcSEcCtD
Tetrahydrobiopterin—Body temperature increased—Conjugated Estrogens—prostate cancer	0.000142	0.00128	CcSEcCtD
Tetrahydrobiopterin—Mediastinal disorder—Etoposide—prostate cancer	0.000141	0.00127	CcSEcCtD
Tetrahydrobiopterin—Nervous system disorder—Estradiol—prostate cancer	0.000141	0.00127	CcSEcCtD
Tetrahydrobiopterin—Infestation—Capecitabine—prostate cancer	0.00014	0.00126	CcSEcCtD
Tetrahydrobiopterin—Infestation NOS—Capecitabine—prostate cancer	0.00014	0.00126	CcSEcCtD
Tetrahydrobiopterin—Vomiting—Ethinyl Estradiol—prostate cancer	0.00014	0.00126	CcSEcCtD
Tetrahydrobiopterin—Arthralgia—Mitoxantrone—prostate cancer	0.00014	0.00126	CcSEcCtD
Tetrahydrobiopterin—Skin disorder—Estradiol—prostate cancer	0.000139	0.00126	CcSEcCtD
Tetrahydrobiopterin—Rash—Ethinyl Estradiol—prostate cancer	0.000139	0.00125	CcSEcCtD
Tetrahydrobiopterin—Dermatitis—Ethinyl Estradiol—prostate cancer	0.000139	0.00125	CcSEcCtD
Tetrahydrobiopterin—Acute coronary syndrome—Capecitabine—prostate cancer	0.000138	0.00125	CcSEcCtD
Tetrahydrobiopterin—Headache—Ethinyl Estradiol—prostate cancer	0.000138	0.00124	CcSEcCtD
Tetrahydrobiopterin—Myocardial infarction—Capecitabine—prostate cancer	0.000138	0.00124	CcSEcCtD
Tetrahydrobiopterin—Urinary tract infection—Capecitabine—prostate cancer	0.000136	0.00123	CcSEcCtD
Tetrahydrobiopterin—Anaphylactic shock—Mitoxantrone—prostate cancer	0.000134	0.00121	CcSEcCtD
Tetrahydrobiopterin—Hypersensitivity—Goserelin—prostate cancer	0.000133	0.0012	CcSEcCtD
Tetrahydrobiopterin—Infection—Mitoxantrone—prostate cancer	0.000133	0.0012	CcSEcCtD
Tetrahydrobiopterin—Hypersensitivity—Conjugated Estrogens—prostate cancer	0.000132	0.00119	CcSEcCtD
Tetrahydrobiopterin—Neutropenia—Prednisone—prostate cancer	0.000131	0.00118	CcSEcCtD
Tetrahydrobiopterin—Musculoskeletal discomfort—Estradiol—prostate cancer	0.000131	0.00118	CcSEcCtD
Tetrahydrobiopterin—Nausea—Ethinyl Estradiol—prostate cancer	0.000131	0.00118	CcSEcCtD
Tetrahydrobiopterin—Skin disorder—Mitoxantrone—prostate cancer	0.00013	0.00117	CcSEcCtD
Tetrahydrobiopterin—Pharyngitis—Docetaxel—prostate cancer	0.000129	0.00116	CcSEcCtD
Tetrahydrobiopterin—Oedema peripheral—Docetaxel—prostate cancer	0.000128	0.00116	CcSEcCtD
Tetrahydrobiopterin—Gastrointestinal haemorrhage—Epirubicin—prostate cancer	0.000127	0.00114	CcSEcCtD
Tetrahydrobiopterin—Dyspepsia—Estradiol—prostate cancer	0.000126	0.00114	CcSEcCtD
Tetrahydrobiopterin—Pharyngitis—Capecitabine—prostate cancer	0.000125	0.00113	CcSEcCtD
Tetrahydrobiopterin—Oedema peripheral—Capecitabine—prostate cancer	0.000124	0.00112	CcSEcCtD
Tetrahydrobiopterin—Gastrointestinal disorder—Estradiol—prostate cancer	0.000124	0.00112	CcSEcCtD
Tetrahydrobiopterin—Diarrhoea—Goserelin—prostate cancer	0.000124	0.00112	CcSEcCtD
Tetrahydrobiopterin—Acute coronary syndrome—Prednisone—prostate cancer	0.000123	0.00111	CcSEcCtD
Tetrahydrobiopterin—Diarrhoea—Conjugated Estrogens—prostate cancer	0.000123	0.00111	CcSEcCtD
Tetrahydrobiopterin—Myocardial infarction—Prednisone—prostate cancer	0.000123	0.0011	CcSEcCtD
Tetrahydrobiopterin—Musculoskeletal discomfort—Mitoxantrone—prostate cancer	0.000122	0.0011	CcSEcCtD
Tetrahydrobiopterin—Dizziness—Goserelin—prostate cancer	0.00012	0.00108	CcSEcCtD
Tetrahydrobiopterin—Cough—Etoposide—prostate cancer	0.000119	0.00107	CcSEcCtD
Tetrahydrobiopterin—Dizziness—Conjugated Estrogens—prostate cancer	0.000119	0.00107	CcSEcCtD
Tetrahydrobiopterin—Convulsion—Etoposide—prostate cancer	0.000118	0.00106	CcSEcCtD
Tetrahydrobiopterin—Dyspepsia—Mitoxantrone—prostate cancer	0.000118	0.00106	CcSEcCtD
Tetrahydrobiopterin—Gastrointestinal haemorrhage—Doxorubicin—prostate cancer	0.000117	0.00106	CcSEcCtD
Tetrahydrobiopterin—Gastrointestinal pain—Estradiol—prostate cancer	0.000117	0.00106	CcSEcCtD
Tetrahydrobiopterin—Mediastinal disorder—Docetaxel—prostate cancer	0.000117	0.00106	CcSEcCtD
Tetrahydrobiopterin—Abdominal pain upper—Epirubicin—prostate cancer	0.000116	0.00104	CcSEcCtD
Tetrahydrobiopterin—Unspecified disorder of skin and subcutaneous tissue—Etoposide—prostate cancer	0.000115	0.00104	CcSEcCtD
Tetrahydrobiopterin—Vomiting—Goserelin—prostate cancer	0.000115	0.00104	CcSEcCtD
Tetrahydrobiopterin—Rash—Goserelin—prostate cancer	0.000114	0.00103	CcSEcCtD
Tetrahydrobiopterin—Dermatitis—Goserelin—prostate cancer	0.000114	0.00103	CcSEcCtD
Tetrahydrobiopterin—Vomiting—Conjugated Estrogens—prostate cancer	0.000114	0.00103	CcSEcCtD
Tetrahydrobiopterin—Mediastinal disorder—Capecitabine—prostate cancer	0.000114	0.00102	CcSEcCtD
Tetrahydrobiopterin—Abdominal pain—Estradiol—prostate cancer	0.000113	0.00102	CcSEcCtD
Tetrahydrobiopterin—Body temperature increased—Estradiol—prostate cancer	0.000113	0.00102	CcSEcCtD
Tetrahydrobiopterin—Nasopharyngitis—Epirubicin—prostate cancer	0.000113	0.00102	CcSEcCtD
Tetrahydrobiopterin—Headache—Goserelin—prostate cancer	0.000113	0.00102	CcSEcCtD
Tetrahydrobiopterin—Malnutrition—Docetaxel—prostate cancer	0.000113	0.00102	CcSEcCtD
Tetrahydrobiopterin—Rash—Conjugated Estrogens—prostate cancer	0.000113	0.00102	CcSEcCtD
Tetrahydrobiopterin—Dermatitis—Conjugated Estrogens—prostate cancer	0.000113	0.00102	CcSEcCtD
Tetrahydrobiopterin—Headache—Conjugated Estrogens—prostate cancer	0.000112	0.00101	CcSEcCtD
Tetrahydrobiopterin—Gastritis—Epirubicin—prostate cancer	0.000112	0.00101	CcSEcCtD
Tetrahydrobiopterin—Anaphylactic shock—Etoposide—prostate cancer	0.000111	0.001	CcSEcCtD
Tetrahydrobiopterin—Infection—Etoposide—prostate cancer	0.000111	0.000996	CcSEcCtD
Tetrahydrobiopterin—Malnutrition—Capecitabine—prostate cancer	0.00011	0.000988	CcSEcCtD
Tetrahydrobiopterin—Gastrointestinal pain—Mitoxantrone—prostate cancer	0.000109	0.000985	CcSEcCtD
Tetrahydrobiopterin—Skin disorder—Etoposide—prostate cancer	0.000108	0.000974	CcSEcCtD
Tetrahydrobiopterin—Nausea—Goserelin—prostate cancer	0.000108	0.000969	CcSEcCtD
Tetrahydrobiopterin—Abdominal pain upper—Doxorubicin—prostate cancer	0.000107	0.000966	CcSEcCtD
Tetrahydrobiopterin—Nausea—Conjugated Estrogens—prostate cancer	0.000107	0.00096	CcSEcCtD
Tetrahydrobiopterin—Hypersensitivity—Estradiol—prostate cancer	0.000106	0.000953	CcSEcCtD
Tetrahydrobiopterin—Abdominal pain—Mitoxantrone—prostate cancer	0.000106	0.000953	CcSEcCtD
Tetrahydrobiopterin—Body temperature increased—Mitoxantrone—prostate cancer	0.000106	0.000953	CcSEcCtD
Tetrahydrobiopterin—Nasopharyngitis—Doxorubicin—prostate cancer	0.000105	0.000946	CcSEcCtD
Tetrahydrobiopterin—Gastritis—Doxorubicin—prostate cancer	0.000104	0.000936	CcSEcCtD
Tetrahydrobiopterin—Neutropenia—Epirubicin—prostate cancer	0.000103	0.000924	CcSEcCtD
Tetrahydrobiopterin—Upper respiratory tract infection—Epirubicin—prostate cancer	0.000102	0.000918	CcSEcCtD
Tetrahydrobiopterin—Cough—Docetaxel—prostate cancer	9.88e-05	0.000891	CcSEcCtD
Tetrahydrobiopterin—Hypersensitivity—Mitoxantrone—prostate cancer	9.85e-05	0.000888	CcSEcCtD
Tetrahydrobiopterin—Diarrhoea—Estradiol—prostate cancer	9.82e-05	0.000885	CcSEcCtD
Tetrahydrobiopterin—Convulsion—Docetaxel—prostate cancer	9.81e-05	0.000884	CcSEcCtD
Tetrahydrobiopterin—Infestation NOS—Epirubicin—prostate cancer	9.78e-05	0.000881	CcSEcCtD
Tetrahydrobiopterin—Infestation—Epirubicin—prostate cancer	9.78e-05	0.000881	CcSEcCtD
Tetrahydrobiopterin—Malnutrition—Prednisone—prostate cancer	9.77e-05	0.00088	CcSEcCtD
Tetrahydrobiopterin—Arthralgia—Docetaxel—prostate cancer	9.64e-05	0.000869	CcSEcCtD
Tetrahydrobiopterin—Gastrointestinal disorder—Etoposide—prostate cancer	9.6e-05	0.000865	CcSEcCtD
Tetrahydrobiopterin—Unspecified disorder of skin and subcutaneous tissue—Docetaxel—prostate cancer	9.58e-05	0.000863	CcSEcCtD
Tetrahydrobiopterin—Cough—Capecitabine—prostate cancer	9.57e-05	0.000862	CcSEcCtD
Tetrahydrobiopterin—Urinary tract infection—Epirubicin—prostate cancer	9.5e-05	0.000856	CcSEcCtD
Tetrahydrobiopterin—Dizziness—Estradiol—prostate cancer	9.49e-05	0.000855	CcSEcCtD
Tetrahydrobiopterin—Neutropenia—Doxorubicin—prostate cancer	9.49e-05	0.000855	CcSEcCtD
Tetrahydrobiopterin—Upper respiratory tract infection—Doxorubicin—prostate cancer	9.43e-05	0.00085	CcSEcCtD
Tetrahydrobiopterin—Arthralgia—Capecitabine—prostate cancer	9.34e-05	0.000841	CcSEcCtD
Tetrahydrobiopterin—Unspecified disorder of skin and subcutaneous tissue—Capecitabine—prostate cancer	9.27e-05	0.000836	CcSEcCtD
Tetrahydrobiopterin—Anaphylactic shock—Docetaxel—prostate cancer	9.25e-05	0.000833	CcSEcCtD
Tetrahydrobiopterin—Infection—Docetaxel—prostate cancer	9.18e-05	0.000828	CcSEcCtD
Tetrahydrobiopterin—Diarrhoea—Mitoxantrone—prostate cancer	9.15e-05	0.000825	CcSEcCtD
Tetrahydrobiopterin—Vomiting—Estradiol—prostate cancer	9.13e-05	0.000822	CcSEcCtD
Tetrahydrobiopterin—Gastrointestinal pain—Etoposide—prostate cancer	9.1e-05	0.00082	CcSEcCtD
Tetrahydrobiopterin—Nervous system disorder—Docetaxel—prostate cancer	9.07e-05	0.000817	CcSEcCtD
Tetrahydrobiopterin—Rash—Estradiol—prostate cancer	9.05e-05	0.000815	CcSEcCtD
Tetrahydrobiopterin—Infestation—Doxorubicin—prostate cancer	9.05e-05	0.000815	CcSEcCtD
Tetrahydrobiopterin—Infestation NOS—Doxorubicin—prostate cancer	9.05e-05	0.000815	CcSEcCtD
Tetrahydrobiopterin—Dermatitis—Estradiol—prostate cancer	9.04e-05	0.000815	CcSEcCtD
Tetrahydrobiopterin—Headache—Estradiol—prostate cancer	8.99e-05	0.00081	CcSEcCtD
Tetrahydrobiopterin—Skin disorder—Docetaxel—prostate cancer	8.98e-05	0.000809	CcSEcCtD
Tetrahydrobiopterin—Agitation—Prednisone—prostate cancer	8.98e-05	0.000809	CcSEcCtD
Tetrahydrobiopterin—Infection—Capecitabine—prostate cancer	8.89e-05	0.000801	CcSEcCtD
Tetrahydrobiopterin—Abdominal pain—Etoposide—prostate cancer	8.79e-05	0.000792	CcSEcCtD
Tetrahydrobiopterin—Body temperature increased—Etoposide—prostate cancer	8.79e-05	0.000792	CcSEcCtD
Tetrahydrobiopterin—Urinary tract infection—Doxorubicin—prostate cancer	8.79e-05	0.000792	CcSEcCtD
Tetrahydrobiopterin—Nervous system disorder—Capecitabine—prostate cancer	8.78e-05	0.000791	CcSEcCtD
Tetrahydrobiopterin—Pharyngitis—Epirubicin—prostate cancer	8.71e-05	0.000785	CcSEcCtD
Tetrahydrobiopterin—Skin disorder—Capecitabine—prostate cancer	8.69e-05	0.000783	CcSEcCtD
Tetrahydrobiopterin—Oedema peripheral—Epirubicin—prostate cancer	8.65e-05	0.000779	CcSEcCtD
Tetrahydrobiopterin—Nausea—Estradiol—prostate cancer	8.53e-05	0.000768	CcSEcCtD
Tetrahydrobiopterin—Vomiting—Mitoxantrone—prostate cancer	8.5e-05	0.000766	CcSEcCtD
Tetrahydrobiopterin—Convulsion—Prednisone—prostate cancer	8.46e-05	0.000763	CcSEcCtD
Tetrahydrobiopterin—Rash—Mitoxantrone—prostate cancer	8.43e-05	0.00076	CcSEcCtD
Tetrahydrobiopterin—Dermatitis—Mitoxantrone—prostate cancer	8.42e-05	0.000759	CcSEcCtD
Tetrahydrobiopterin—Musculoskeletal discomfort—Docetaxel—prostate cancer	8.42e-05	0.000759	CcSEcCtD
Tetrahydrobiopterin—Headache—Mitoxantrone—prostate cancer	8.38e-05	0.000755	CcSEcCtD
Tetrahydrobiopterin—Arthralgia—Prednisone—prostate cancer	8.32e-05	0.000749	CcSEcCtD
Tetrahydrobiopterin—Unspecified disorder of skin and subcutaneous tissue—Prednisone—prostate cancer	8.26e-05	0.000744	CcSEcCtD
Tetrahydrobiopterin—Hypersensitivity—Etoposide—prostate cancer	8.2e-05	0.000739	CcSEcCtD
Tetrahydrobiopterin—Musculoskeletal discomfort—Capecitabine—prostate cancer	8.16e-05	0.000735	CcSEcCtD
Tetrahydrobiopterin—Dyspepsia—Docetaxel—prostate cancer	8.14e-05	0.000733	CcSEcCtD
Tetrahydrobiopterin—Pharyngitis—Doxorubicin—prostate cancer	8.06e-05	0.000726	CcSEcCtD
Tetrahydrobiopterin—Oedema peripheral—Doxorubicin—prostate cancer	8e-05	0.000721	CcSEcCtD
Tetrahydrobiopterin—Gastrointestinal disorder—Docetaxel—prostate cancer	7.98e-05	0.000719	CcSEcCtD
Tetrahydrobiopterin—Anaphylactic shock—Prednisone—prostate cancer	7.97e-05	0.000718	CcSEcCtD
Tetrahydrobiopterin—Nausea—Mitoxantrone—prostate cancer	7.94e-05	0.000716	CcSEcCtD
Tetrahydrobiopterin—Infection—Prednisone—prostate cancer	7.92e-05	0.000714	CcSEcCtD
Tetrahydrobiopterin—Mediastinal disorder—Epirubicin—prostate cancer	7.91e-05	0.000713	CcSEcCtD
Tetrahydrobiopterin—Dyspepsia—Capecitabine—prostate cancer	7.88e-05	0.00071	CcSEcCtD
Tetrahydrobiopterin—Nervous system disorder—Prednisone—prostate cancer	7.82e-05	0.000705	CcSEcCtD
Tetrahydrobiopterin—Skin disorder—Prednisone—prostate cancer	7.74e-05	0.000698	CcSEcCtD
Tetrahydrobiopterin—Gastrointestinal disorder—Capecitabine—prostate cancer	7.73e-05	0.000696	CcSEcCtD
Tetrahydrobiopterin—Malnutrition—Epirubicin—prostate cancer	7.64e-05	0.000688	CcSEcCtD
Tetrahydrobiopterin—Diarrhoea—Etoposide—prostate cancer	7.61e-05	0.000686	CcSEcCtD
Tetrahydrobiopterin—Gastrointestinal pain—Docetaxel—prostate cancer	7.56e-05	0.000681	CcSEcCtD
Tetrahydrobiopterin—Dizziness—Etoposide—prostate cancer	7.36e-05	0.000663	CcSEcCtD
Tetrahydrobiopterin—Gastrointestinal pain—Capecitabine—prostate cancer	7.32e-05	0.00066	CcSEcCtD
Tetrahydrobiopterin—Mediastinal disorder—Doxorubicin—prostate cancer	7.32e-05	0.00066	CcSEcCtD
Tetrahydrobiopterin—Abdominal pain—Docetaxel—prostate cancer	7.31e-05	0.000659	CcSEcCtD
Tetrahydrobiopterin—Body temperature increased—Docetaxel—prostate cancer	7.31e-05	0.000659	CcSEcCtD
Tetrahydrobiopterin—Musculoskeletal discomfort—Prednisone—prostate cancer	7.26e-05	0.000655	CcSEcCtD
Tetrahydrobiopterin—Abdominal pain—Capecitabine—prostate cancer	7.08e-05	0.000638	CcSEcCtD
Tetrahydrobiopterin—Body temperature increased—Capecitabine—prostate cancer	7.08e-05	0.000638	CcSEcCtD
Tetrahydrobiopterin—Vomiting—Etoposide—prostate cancer	7.07e-05	0.000637	CcSEcCtD
Tetrahydrobiopterin—Malnutrition—Doxorubicin—prostate cancer	7.07e-05	0.000637	CcSEcCtD
Tetrahydrobiopterin—Agitation—Epirubicin—prostate cancer	7.02e-05	0.000633	CcSEcCtD
Tetrahydrobiopterin—Dyspepsia—Prednisone—prostate cancer	7.02e-05	0.000632	CcSEcCtD
Tetrahydrobiopterin—Rash—Etoposide—prostate cancer	7.01e-05	0.000632	CcSEcCtD
Tetrahydrobiopterin—Dermatitis—Etoposide—prostate cancer	7.01e-05	0.000631	CcSEcCtD
Tetrahydrobiopterin—Headache—Etoposide—prostate cancer	6.97e-05	0.000628	CcSEcCtD
Tetrahydrobiopterin—Hypersensitivity—Docetaxel—prostate cancer	6.81e-05	0.000614	CcSEcCtD
Tetrahydrobiopterin—Cough—Epirubicin—prostate cancer	6.67e-05	0.000601	CcSEcCtD
Tetrahydrobiopterin—Convulsion—Epirubicin—prostate cancer	6.62e-05	0.000597	CcSEcCtD
Tetrahydrobiopterin—Nausea—Etoposide—prostate cancer	6.61e-05	0.000595	CcSEcCtD
Tetrahydrobiopterin—Hypersensitivity—Capecitabine—prostate cancer	6.59e-05	0.000594	CcSEcCtD
Tetrahydrobiopterin—Gastrointestinal pain—Prednisone—prostate cancer	6.52e-05	0.000587	CcSEcCtD
Tetrahydrobiopterin—Arthralgia—Epirubicin—prostate cancer	6.5e-05	0.000586	CcSEcCtD
Tetrahydrobiopterin—Agitation—Doxorubicin—prostate cancer	6.5e-05	0.000585	CcSEcCtD
Tetrahydrobiopterin—Unspecified disorder of skin and subcutaneous tissue—Epirubicin—prostate cancer	6.46e-05	0.000582	CcSEcCtD
Tetrahydrobiopterin—Diarrhoea—Docetaxel—prostate cancer	6.33e-05	0.00057	CcSEcCtD
Tetrahydrobiopterin—Abdominal pain—Prednisone—prostate cancer	6.3e-05	0.000568	CcSEcCtD
Tetrahydrobiopterin—Body temperature increased—Prednisone—prostate cancer	6.3e-05	0.000568	CcSEcCtD
Tetrahydrobiopterin—Anaphylactic shock—Epirubicin—prostate cancer	6.24e-05	0.000562	CcSEcCtD
Tetrahydrobiopterin—Infection—Epirubicin—prostate cancer	6.2e-05	0.000558	CcSEcCtD
Tetrahydrobiopterin—Cough—Doxorubicin—prostate cancer	6.17e-05	0.000556	CcSEcCtD
Tetrahydrobiopterin—Convulsion—Doxorubicin—prostate cancer	6.13e-05	0.000552	CcSEcCtD
Tetrahydrobiopterin—Diarrhoea—Capecitabine—prostate cancer	6.12e-05	0.000552	CcSEcCtD
Tetrahydrobiopterin—Nervous system disorder—Epirubicin—prostate cancer	6.12e-05	0.000551	CcSEcCtD
Tetrahydrobiopterin—Dizziness—Docetaxel—prostate cancer	6.11e-05	0.000551	CcSEcCtD
Tetrahydrobiopterin—Skin disorder—Epirubicin—prostate cancer	6.06e-05	0.000546	CcSEcCtD
Tetrahydrobiopterin—Arthralgia—Doxorubicin—prostate cancer	6.02e-05	0.000542	CcSEcCtD
Tetrahydrobiopterin—Unspecified disorder of skin and subcutaneous tissue—Doxorubicin—prostate cancer	5.98e-05	0.000539	CcSEcCtD
Tetrahydrobiopterin—Dizziness—Capecitabine—prostate cancer	5.92e-05	0.000533	CcSEcCtD
Tetrahydrobiopterin—Vomiting—Docetaxel—prostate cancer	5.88e-05	0.00053	CcSEcCtD
Tetrahydrobiopterin—Hypersensitivity—Prednisone—prostate cancer	5.87e-05	0.000529	CcSEcCtD
Tetrahydrobiopterin—Rash—Docetaxel—prostate cancer	5.83e-05	0.000525	CcSEcCtD
Tetrahydrobiopterin—Dermatitis—Docetaxel—prostate cancer	5.82e-05	0.000525	CcSEcCtD
Tetrahydrobiopterin—Headache—Docetaxel—prostate cancer	5.79e-05	0.000522	CcSEcCtD
Tetrahydrobiopterin—Anaphylactic shock—Doxorubicin—prostate cancer	5.77e-05	0.00052	CcSEcCtD
Tetrahydrobiopterin—Infection—Doxorubicin—prostate cancer	5.73e-05	0.000517	CcSEcCtD
Tetrahydrobiopterin—Vomiting—Capecitabine—prostate cancer	5.69e-05	0.000513	CcSEcCtD
Tetrahydrobiopterin—Musculoskeletal discomfort—Epirubicin—prostate cancer	5.68e-05	0.000512	CcSEcCtD
Tetrahydrobiopterin—Nervous system disorder—Doxorubicin—prostate cancer	5.66e-05	0.00051	CcSEcCtD
Tetrahydrobiopterin—Rash—Capecitabine—prostate cancer	5.64e-05	0.000509	CcSEcCtD
Tetrahydrobiopterin—Dermatitis—Capecitabine—prostate cancer	5.64e-05	0.000508	CcSEcCtD
Tetrahydrobiopterin—Headache—Capecitabine—prostate cancer	5.61e-05	0.000505	CcSEcCtD
Tetrahydrobiopterin—Skin disorder—Doxorubicin—prostate cancer	5.6e-05	0.000505	CcSEcCtD
Tetrahydrobiopterin—Nausea—Docetaxel—prostate cancer	5.49e-05	0.000495	CcSEcCtD
Tetrahydrobiopterin—Dyspepsia—Epirubicin—prostate cancer	5.49e-05	0.000495	CcSEcCtD
Tetrahydrobiopterin—Diarrhoea—Prednisone—prostate cancer	5.46e-05	0.000492	CcSEcCtD
Tetrahydrobiopterin—Gastrointestinal disorder—Epirubicin—prostate cancer	5.38e-05	0.000485	CcSEcCtD
Tetrahydrobiopterin—Nausea—Capecitabine—prostate cancer	5.32e-05	0.000479	CcSEcCtD
Tetrahydrobiopterin—Dizziness—Prednisone—prostate cancer	5.27e-05	0.000475	CcSEcCtD
Tetrahydrobiopterin—Musculoskeletal discomfort—Doxorubicin—prostate cancer	5.26e-05	0.000474	CcSEcCtD
Tetrahydrobiopterin—Gastrointestinal pain—Epirubicin—prostate cancer	5.1e-05	0.000459	CcSEcCtD
Tetrahydrobiopterin—Dyspepsia—Doxorubicin—prostate cancer	5.08e-05	0.000458	CcSEcCtD
Tetrahydrobiopterin—Vomiting—Prednisone—prostate cancer	5.07e-05	0.000457	CcSEcCtD
Tetrahydrobiopterin—Rash—Prednisone—prostate cancer	5.03e-05	0.000453	CcSEcCtD
Tetrahydrobiopterin—Dermatitis—Prednisone—prostate cancer	5.02e-05	0.000453	CcSEcCtD
Tetrahydrobiopterin—Headache—Prednisone—prostate cancer	4.99e-05	0.00045	CcSEcCtD
Tetrahydrobiopterin—Gastrointestinal disorder—Doxorubicin—prostate cancer	4.98e-05	0.000449	CcSEcCtD
Tetrahydrobiopterin—Body temperature increased—Epirubicin—prostate cancer	4.93e-05	0.000444	CcSEcCtD
Tetrahydrobiopterin—Abdominal pain—Epirubicin—prostate cancer	4.93e-05	0.000444	CcSEcCtD
Tetrahydrobiopterin—Nausea—Prednisone—prostate cancer	4.74e-05	0.000427	CcSEcCtD
Tetrahydrobiopterin—Gastrointestinal pain—Doxorubicin—prostate cancer	4.72e-05	0.000425	CcSEcCtD
Tetrahydrobiopterin—Hypersensitivity—Epirubicin—prostate cancer	4.59e-05	0.000414	CcSEcCtD
Tetrahydrobiopterin—Abdominal pain—Doxorubicin—prostate cancer	4.56e-05	0.000411	CcSEcCtD
Tetrahydrobiopterin—Body temperature increased—Doxorubicin—prostate cancer	4.56e-05	0.000411	CcSEcCtD
Tetrahydrobiopterin—Diarrhoea—Epirubicin—prostate cancer	4.27e-05	0.000384	CcSEcCtD
Tetrahydrobiopterin—Hypersensitivity—Doxorubicin—prostate cancer	4.25e-05	0.000383	CcSEcCtD
Tetrahydrobiopterin—Dizziness—Epirubicin—prostate cancer	4.12e-05	0.000372	CcSEcCtD
Tetrahydrobiopterin—Vomiting—Epirubicin—prostate cancer	3.96e-05	0.000357	CcSEcCtD
Tetrahydrobiopterin—Diarrhoea—Doxorubicin—prostate cancer	3.95e-05	0.000356	CcSEcCtD
Tetrahydrobiopterin—Rash—Epirubicin—prostate cancer	3.93e-05	0.000354	CcSEcCtD
Tetrahydrobiopterin—Dermatitis—Epirubicin—prostate cancer	3.93e-05	0.000354	CcSEcCtD
Tetrahydrobiopterin—Headache—Epirubicin—prostate cancer	3.91e-05	0.000352	CcSEcCtD
Tetrahydrobiopterin—Dizziness—Doxorubicin—prostate cancer	3.82e-05	0.000344	CcSEcCtD
Tetrahydrobiopterin—Nausea—Epirubicin—prostate cancer	3.7e-05	0.000334	CcSEcCtD
Tetrahydrobiopterin—Vomiting—Doxorubicin—prostate cancer	3.67e-05	0.000331	CcSEcCtD
Tetrahydrobiopterin—Rash—Doxorubicin—prostate cancer	3.64e-05	0.000328	CcSEcCtD
Tetrahydrobiopterin—Dermatitis—Doxorubicin—prostate cancer	3.63e-05	0.000328	CcSEcCtD
Tetrahydrobiopterin—Headache—Doxorubicin—prostate cancer	3.61e-05	0.000326	CcSEcCtD
Tetrahydrobiopterin—Nausea—Doxorubicin—prostate cancer	3.43e-05	0.000309	CcSEcCtD
Tetrahydrobiopterin—PAH—Metabolism—PTEN—prostate cancer	8.02e-06	6.32e-05	CbGpPWpGaD
Tetrahydrobiopterin—PTGS2—Metabolism of lipids and lipoproteins—LPL—prostate cancer	8.01e-06	6.31e-05	CbGpPWpGaD
Tetrahydrobiopterin—PTGS2—Integrated Pancreatic Cancer Pathway—MYC—prostate cancer	7.98e-06	6.29e-05	CbGpPWpGaD
Tetrahydrobiopterin—PTGS2—Integrated Pancreatic Cancer Pathway—TGFB1—prostate cancer	7.96e-06	6.28e-05	CbGpPWpGaD
Tetrahydrobiopterin—PAH—Disease—MYC—prostate cancer	7.96e-06	6.28e-05	CbGpPWpGaD
Tetrahydrobiopterin—NOS3—Signaling Pathways—ITPR1—prostate cancer	7.95e-06	6.27e-05	CbGpPWpGaD
Tetrahydrobiopterin—PAH—Disease—TGFB1—prostate cancer	7.94e-06	6.26e-05	CbGpPWpGaD
Tetrahydrobiopterin—PTGS2—Metabolism—GSTA4—prostate cancer	7.91e-06	6.24e-05	CbGpPWpGaD
Tetrahydrobiopterin—PTGS2—Metabolism—TBXAS1—prostate cancer	7.91e-06	6.24e-05	CbGpPWpGaD
Tetrahydrobiopterin—TH—Metabolism—NOS3—prostate cancer	7.9e-06	6.23e-05	CbGpPWpGaD
Tetrahydrobiopterin—NOS3—Disease—APC—prostate cancer	7.88e-06	6.21e-05	CbGpPWpGaD
Tetrahydrobiopterin—NOS3—Metabolism—MTHFR—prostate cancer	7.85e-06	6.19e-05	CbGpPWpGaD
Tetrahydrobiopterin—PTGS2—Disease—NPPA—prostate cancer	7.83e-06	6.17e-05	CbGpPWpGaD
Tetrahydrobiopterin—PTGS2—Disease—HIST1H4H—prostate cancer	7.83e-06	6.17e-05	CbGpPWpGaD
Tetrahydrobiopterin—PTGS2—Integrated Pancreatic Cancer Pathway—EGFR—prostate cancer	7.81e-06	6.16e-05	CbGpPWpGaD
Tetrahydrobiopterin—PAH—Disease—EGFR—prostate cancer	7.79e-06	6.14e-05	CbGpPWpGaD
Tetrahydrobiopterin—NOS3—Disease—IRS1—prostate cancer	7.79e-06	6.14e-05	CbGpPWpGaD
Tetrahydrobiopterin—NOS3—Disease—EGF—prostate cancer	7.79e-06	6.14e-05	CbGpPWpGaD
Tetrahydrobiopterin—TPH1—Metabolism—PIK3CA—prostate cancer	7.74e-06	6.1e-05	CbGpPWpGaD
Tetrahydrobiopterin—PTGS2—Metabolism of lipids and lipoproteins—CYP1A1—prostate cancer	7.73e-06	6.1e-05	CbGpPWpGaD
Tetrahydrobiopterin—PTGS2—Metabolism—GSTA2—prostate cancer	7.71e-06	6.08e-05	CbGpPWpGaD
Tetrahydrobiopterin—NOS3—Metabolism—PPARA—prostate cancer	7.7e-06	6.07e-05	CbGpPWpGaD
Tetrahydrobiopterin—PAH—Metabolism—EP300—prostate cancer	7.65e-06	6.03e-05	CbGpPWpGaD
Tetrahydrobiopterin—PTGS2—Metabolism—ABCG5—prostate cancer	7.62e-06	6e-05	CbGpPWpGaD
Tetrahydrobiopterin—PTGS2—Metabolism—SULT1A1—prostate cancer	7.62e-06	6e-05	CbGpPWpGaD
Tetrahydrobiopterin—NOS3—Signaling Pathways—IGF1R—prostate cancer	7.6e-06	6e-05	CbGpPWpGaD
Tetrahydrobiopterin—NOS3—Hemostasis—PIK3CA—prostate cancer	7.6e-06	5.99e-05	CbGpPWpGaD
Tetrahydrobiopterin—NOS3—Disease—GSK3B—prostate cancer	7.56e-06	5.96e-05	CbGpPWpGaD
Tetrahydrobiopterin—NOS3—Disease—INS—prostate cancer	7.46e-06	5.88e-05	CbGpPWpGaD
Tetrahydrobiopterin—PTGS2—Metabolism—GSTA1—prostate cancer	7.44e-06	5.87e-05	CbGpPWpGaD
Tetrahydrobiopterin—PTGS2—Integrated Pancreatic Cancer Pathway—KRAS—prostate cancer	7.38e-06	5.81e-05	CbGpPWpGaD
Tetrahydrobiopterin—PTGS2—Metabolism—GSTO1—prostate cancer	7.36e-06	5.8e-05	CbGpPWpGaD
Tetrahydrobiopterin—PTGS2—Metabolism—HSD3B2—prostate cancer	7.36e-06	5.8e-05	CbGpPWpGaD
Tetrahydrobiopterin—PTGS2—Metabolism—NAT2—prostate cancer	7.36e-06	5.8e-05	CbGpPWpGaD
Tetrahydrobiopterin—PAH—Disease—KRAS—prostate cancer	7.35e-06	5.8e-05	CbGpPWpGaD
Tetrahydrobiopterin—NOS3—Hemostasis—TP53—prostate cancer	7.35e-06	5.8e-05	CbGpPWpGaD
Tetrahydrobiopterin—NOS3—Disease—CREBBP—prostate cancer	7.3e-06	5.76e-05	CbGpPWpGaD
Tetrahydrobiopterin—TH—Metabolism—PIK3CB—prostate cancer	7.29e-06	5.75e-05	CbGpPWpGaD
Tetrahydrobiopterin—NOS3—Signaling Pathways—LPL—prostate cancer	7.29e-06	5.75e-05	CbGpPWpGaD
Tetrahydrobiopterin—NOS3—Metabolism—CAV1—prostate cancer	7.24e-06	5.71e-05	CbGpPWpGaD
Tetrahydrobiopterin—NOS3—Signaling Pathways—PDGFRB—prostate cancer	7.23e-06	5.7e-05	CbGpPWpGaD
Tetrahydrobiopterin—TH—Metabolism—PTGS2—prostate cancer	7.23e-06	5.7e-05	CbGpPWpGaD
Tetrahydrobiopterin—PTGS2—Metabolism of lipids and lipoproteins—PPARA—prostate cancer	7.07e-06	5.58e-05	CbGpPWpGaD
Tetrahydrobiopterin—PTGS2—Metabolism—PLCB2—prostate cancer	7.05e-06	5.56e-05	CbGpPWpGaD
Tetrahydrobiopterin—PTGS2—Metabolism—CYP2C18—prostate cancer	7.05e-06	5.56e-05	CbGpPWpGaD
Tetrahydrobiopterin—PTGS2—Metabolism—LRP2—prostate cancer	7.05e-06	5.56e-05	CbGpPWpGaD
Tetrahydrobiopterin—NOS3—Signaling Pathways—ITGB3—prostate cancer	7.04e-06	5.55e-05	CbGpPWpGaD
Tetrahydrobiopterin—NOS3—Disease—MAP2K1—prostate cancer	6.97e-06	5.5e-05	CbGpPWpGaD
Tetrahydrobiopterin—NOS3—Disease—PIK3CD—prostate cancer	6.92e-06	5.46e-05	CbGpPWpGaD
Tetrahydrobiopterin—PTGS2—Metabolism—P4HB—prostate cancer	6.92e-06	5.45e-05	CbGpPWpGaD
Tetrahydrobiopterin—NOS3—Disease—SERPINE1—prostate cancer	6.85e-06	5.4e-05	CbGpPWpGaD
Tetrahydrobiopterin—NOS3—Signaling Pathways—ERBB3—prostate cancer	6.83e-06	5.39e-05	CbGpPWpGaD
Tetrahydrobiopterin—NOS3—Signaling Pathways—FGFR2—prostate cancer	6.82e-06	5.38e-05	CbGpPWpGaD
Tetrahydrobiopterin—PTGS2—Integrated Pancreatic Cancer Pathway—PIK3CA—prostate cancer	6.78e-06	5.34e-05	CbGpPWpGaD
Tetrahydrobiopterin—PAH—Disease—PIK3CA—prostate cancer	6.76e-06	5.33e-05	CbGpPWpGaD
Tetrahydrobiopterin—PTGS2—Metabolism—SLC22A1—prostate cancer	6.73e-06	5.3e-05	CbGpPWpGaD
Tetrahydrobiopterin—PTGS2—Disease—B2M—prostate cancer	6.66e-06	5.25e-05	CbGpPWpGaD
Tetrahydrobiopterin—PTGS2—Disease—TGFBR1—prostate cancer	6.66e-06	5.25e-05	CbGpPWpGaD
Tetrahydrobiopterin—PTGS2—Metabolism of lipids and lipoproteins—CAV1—prostate cancer	6.65e-06	5.24e-05	CbGpPWpGaD
Tetrahydrobiopterin—NOS3—Disease—FGF2—prostate cancer	6.63e-06	5.23e-05	CbGpPWpGaD
Tetrahydrobiopterin—NOS3—Metabolism—PIK3CG—prostate cancer	6.6e-06	5.2e-05	CbGpPWpGaD
Tetrahydrobiopterin—PTGS2—Metabolism—SULT2A1—prostate cancer	6.56e-06	5.17e-05	CbGpPWpGaD
Tetrahydrobiopterin—PTGS2—Integrated Pancreatic Cancer Pathway—TP53—prostate cancer	6.55e-06	5.17e-05	CbGpPWpGaD
Tetrahydrobiopterin—PTGS2—Disease—AKR1C3—prostate cancer	6.55e-06	5.16e-05	CbGpPWpGaD
Tetrahydrobiopterin—PTGS2—Disease—RPS19—prostate cancer	6.55e-06	5.16e-05	CbGpPWpGaD
Tetrahydrobiopterin—NOS3—Signaling Pathways—TERT—prostate cancer	6.55e-06	5.16e-05	CbGpPWpGaD
Tetrahydrobiopterin—PTGS2—Disease—PRKACB—prostate cancer	6.51e-06	5.14e-05	CbGpPWpGaD
Tetrahydrobiopterin—PTGS2—Metabolism—MED12—prostate cancer	6.45e-06	5.09e-05	CbGpPWpGaD
Tetrahydrobiopterin—PTGS2—Metabolism—GNG5—prostate cancer	6.4e-06	5.05e-05	CbGpPWpGaD
Tetrahydrobiopterin—NOS3—Disease—JAK2—prostate cancer	6.35e-06	5.01e-05	CbGpPWpGaD
Tetrahydrobiopterin—PTGS2—Disease—PPP3CA—prostate cancer	6.35e-06	5.01e-05	CbGpPWpGaD
Tetrahydrobiopterin—TPH1—Metabolism—AKT1—prostate cancer	6.32e-06	4.98e-05	CbGpPWpGaD
Tetrahydrobiopterin—TH—Metabolism—PTEN—prostate cancer	6.3e-06	4.97e-05	CbGpPWpGaD
Tetrahydrobiopterin—NOS3—Signaling Pathways—HIF1A—prostate cancer	6.26e-06	4.94e-05	CbGpPWpGaD
Tetrahydrobiopterin—NOS3—Metabolism—INS—prostate cancer	6.24e-06	4.92e-05	CbGpPWpGaD
Tetrahydrobiopterin—NOS3—Hemostasis—AKT1—prostate cancer	6.21e-06	4.89e-05	CbGpPWpGaD
Tetrahydrobiopterin—NOS3—Disease—MDM2—prostate cancer	6.2e-06	4.89e-05	CbGpPWpGaD
Tetrahydrobiopterin—PTGS2—Metabolism—NCOA3—prostate cancer	6.16e-06	4.86e-05	CbGpPWpGaD
Tetrahydrobiopterin—PTGS2—Disease—PRKCZ—prostate cancer	6.14e-06	4.84e-05	CbGpPWpGaD
Tetrahydrobiopterin—NOS3—Metabolism—CREBBP—prostate cancer	6.12e-06	4.82e-05	CbGpPWpGaD
Tetrahydrobiopterin—NOS3—Disease—ERBB2—prostate cancer	6.12e-06	4.82e-05	CbGpPWpGaD
Tetrahydrobiopterin—NOS3—Signaling Pathways—LEP—prostate cancer	6.11e-06	4.82e-05	CbGpPWpGaD
Tetrahydrobiopterin—PTGS2—Metabolism of lipids and lipoproteins—PIK3CG—prostate cancer	6.06e-06	4.78e-05	CbGpPWpGaD
Tetrahydrobiopterin—NOS3—Signaling Pathways—CAV1—prostate cancer	6.06e-06	4.77e-05	CbGpPWpGaD
Tetrahydrobiopterin—NOS3—Disease—PIK3CB—prostate cancer	6.04e-06	4.76e-05	CbGpPWpGaD
Tetrahydrobiopterin—PTGS2—Disease—CALR—prostate cancer	6.03e-06	4.76e-05	CbGpPWpGaD
Tetrahydrobiopterin—TH—Metabolism—EP300—prostate cancer	6.01e-06	4.74e-05	CbGpPWpGaD
Tetrahydrobiopterin—NOS3—Signaling Pathways—KDR—prostate cancer	5.99e-06	4.72e-05	CbGpPWpGaD
Tetrahydrobiopterin—PAH—Disease—IL6—prostate cancer	5.98e-06	4.72e-05	CbGpPWpGaD
Tetrahydrobiopterin—NOS3—Disease—PTGS2—prostate cancer	5.98e-06	4.71e-05	CbGpPWpGaD
Tetrahydrobiopterin—PTGS2—Disease—FGFR4—prostate cancer	5.93e-06	4.68e-05	CbGpPWpGaD
Tetrahydrobiopterin—PTGS2—Disease—PARP1—prostate cancer	5.93e-06	4.68e-05	CbGpPWpGaD
Tetrahydrobiopterin—PTGS2—Metabolism—HPGDS—prostate cancer	5.88e-06	4.64e-05	CbGpPWpGaD
Tetrahydrobiopterin—PTGS2—Disease—CALCA—prostate cancer	5.86e-06	4.62e-05	CbGpPWpGaD
Tetrahydrobiopterin—PTGS2—Metabolism—CYP2C19—prostate cancer	5.84e-06	4.61e-05	CbGpPWpGaD
Tetrahydrobiopterin—NOS3—Signaling Pathways—ESR1—prostate cancer	5.83e-06	4.6e-05	CbGpPWpGaD
Tetrahydrobiopterin—NOS3—Metabolism—PIK3CD—prostate cancer	5.8e-06	4.57e-05	CbGpPWpGaD
Tetrahydrobiopterin—PTGS2—Metabolism—GSTT1—prostate cancer	5.7e-06	4.5e-05	CbGpPWpGaD
Tetrahydrobiopterin—PTGS2—Metabolism—ACHE—prostate cancer	5.7e-06	4.5e-05	CbGpPWpGaD
Tetrahydrobiopterin—NOS3—Signaling Pathways—BAD—prostate cancer	5.7e-06	4.49e-05	CbGpPWpGaD
Tetrahydrobiopterin—NOS3—Disease—CDKN1B—prostate cancer	5.66e-06	4.47e-05	CbGpPWpGaD
Tetrahydrobiopterin—PAH—Metabolism—PIK3CA—prostate cancer	5.66e-06	4.46e-05	CbGpPWpGaD
Tetrahydrobiopterin—PTGS2—Metabolism—CYP2A6—prostate cancer	5.64e-06	4.44e-05	CbGpPWpGaD
Tetrahydrobiopterin—PTGS2—Disease—HSPA1A—prostate cancer	5.62e-06	4.43e-05	CbGpPWpGaD
Tetrahydrobiopterin—PTGS2—Metabolism of lipids and lipoproteins—CREBBP—prostate cancer	5.62e-06	4.43e-05	CbGpPWpGaD
Tetrahydrobiopterin—PTGS2—Integrated Pancreatic Cancer Pathway—AKT1—prostate cancer	5.54e-06	4.36e-05	CbGpPWpGaD
Tetrahydrobiopterin—PAH—Disease—AKT1—prostate cancer	5.52e-06	4.35e-05	CbGpPWpGaD
Tetrahydrobiopterin—NOS3—Signaling Pathways—APC—prostate cancer	5.52e-06	4.35e-05	CbGpPWpGaD
Tetrahydrobiopterin—NOS3—Signaling Pathways—PIK3CG—prostate cancer	5.52e-06	4.35e-05	CbGpPWpGaD
Tetrahydrobiopterin—PTGS2—Metabolism—AKR1C3—prostate cancer	5.48e-06	4.32e-05	CbGpPWpGaD
Tetrahydrobiopterin—PTGS2—Metabolism—PRKACB—prostate cancer	5.46e-06	4.3e-05	CbGpPWpGaD
Tetrahydrobiopterin—NOS3—Signaling Pathways—EGF—prostate cancer	5.45e-06	4.3e-05	CbGpPWpGaD
Tetrahydrobiopterin—NOS3—Signaling Pathways—IRS1—prostate cancer	5.45e-06	4.3e-05	CbGpPWpGaD
Tetrahydrobiopterin—PTGS2—Metabolism—CYP17A1—prostate cancer	5.4e-06	4.26e-05	CbGpPWpGaD
Tetrahydrobiopterin—PTGS2—Disease—CASP9—prostate cancer	5.39e-06	4.25e-05	CbGpPWpGaD
Tetrahydrobiopterin—NOS3—Disease—CTNNB1—prostate cancer	5.35e-06	4.22e-05	CbGpPWpGaD
Tetrahydrobiopterin—PTGS2—Metabolism of lipids and lipoproteins—PIK3CD—prostate cancer	5.32e-06	4.2e-05	CbGpPWpGaD
Tetrahydrobiopterin—NOS3—Signaling Pathways—GSK3B—prostate cancer	5.29e-06	4.17e-05	CbGpPWpGaD
Tetrahydrobiopterin—NOS3—Disease—CDKN1A—prostate cancer	5.23e-06	4.12e-05	CbGpPWpGaD
Tetrahydrobiopterin—PTGS2—Disease—PRKCQ—prostate cancer	5.22e-06	4.12e-05	CbGpPWpGaD
Tetrahydrobiopterin—NOS3—Signaling Pathways—INS—prostate cancer	5.22e-06	4.12e-05	CbGpPWpGaD
Tetrahydrobiopterin—NOS3—Disease—PTEN—prostate cancer	5.22e-06	4.11e-05	CbGpPWpGaD
Tetrahydrobiopterin—PTGS2—Metabolism—NCOA2—prostate cancer	5.14e-06	4.06e-05	CbGpPWpGaD
Tetrahydrobiopterin—NOS3—Signaling Pathways—CREBBP—prostate cancer	5.11e-06	4.03e-05	CbGpPWpGaD
Tetrahydrobiopterin—NOS3—Metabolism—PIK3CB—prostate cancer	5.05e-06	3.99e-05	CbGpPWpGaD
Tetrahydrobiopterin—NOS3—Signaling Pathways—IGF1—prostate cancer	5.05e-06	3.98e-05	CbGpPWpGaD
Tetrahydrobiopterin—NOS3—Metabolism—PTGS2—prostate cancer	5.01e-06	3.95e-05	CbGpPWpGaD
Tetrahydrobiopterin—NOS3—Disease—EP300—prostate cancer	4.97e-06	3.92e-05	CbGpPWpGaD
Tetrahydrobiopterin—PTGS2—Disease—FGF10—prostate cancer	4.96e-06	3.91e-05	CbGpPWpGaD
Tetrahydrobiopterin—PTGS2—Metabolism—SLC5A5—prostate cancer	4.91e-06	3.87e-05	CbGpPWpGaD
Tetrahydrobiopterin—NOS3—Signaling Pathways—MAP2K1—prostate cancer	4.88e-06	3.85e-05	CbGpPWpGaD
Tetrahydrobiopterin—NOS3—Signaling Pathways—PIK3CD—prostate cancer	4.85e-06	3.82e-05	CbGpPWpGaD
Tetrahydrobiopterin—NOS3—Disease—SRC—prostate cancer	4.84e-06	3.81e-05	CbGpPWpGaD
Tetrahydrobiopterin—NOS3—Signaling Pathways—SERPINE1—prostate cancer	4.8e-06	3.78e-05	CbGpPWpGaD
Tetrahydrobiopterin—PTGS2—Metabolism—CYP2E1—prostate cancer	4.79e-06	3.78e-05	CbGpPWpGaD
Tetrahydrobiopterin—PTGS2—Metabolism—NQO1—prostate cancer	4.74e-06	3.74e-05	CbGpPWpGaD
Tetrahydrobiopterin—PTGS2—Disease—TGFBR2—prostate cancer	4.72e-06	3.72e-05	CbGpPWpGaD
Tetrahydrobiopterin—PTGS2—Metabolism—TH—prostate cancer	4.67e-06	3.68e-05	CbGpPWpGaD
Tetrahydrobiopterin—NOS3—Disease—STAT3—prostate cancer	4.66e-06	3.68e-05	CbGpPWpGaD
Tetrahydrobiopterin—PTGS2—Disease—ITPR1—prostate cancer	4.64e-06	3.66e-05	CbGpPWpGaD
Tetrahydrobiopterin—NOS3—Signaling Pathways—FGF2—prostate cancer	4.64e-06	3.66e-05	CbGpPWpGaD
Tetrahydrobiopterin—PTGS2—Metabolism of lipids and lipoproteins—PIK3CB—prostate cancer	4.64e-06	3.66e-05	CbGpPWpGaD
Tetrahydrobiopterin—PAH—Metabolism—AKT1—prostate cancer	4.62e-06	3.64e-05	CbGpPWpGaD
Tetrahydrobiopterin—PTGS2—Metabolism—CYP3A4—prostate cancer	4.62e-06	3.64e-05	CbGpPWpGaD
Tetrahydrobiopterin—PTGS2—Metabolism—CYP1B1—prostate cancer	4.54e-06	3.58e-05	CbGpPWpGaD
Tetrahydrobiopterin—NOS3—Signaling Pathways—JAK2—prostate cancer	4.45e-06	3.51e-05	CbGpPWpGaD
Tetrahydrobiopterin—TH—Metabolism—PIK3CA—prostate cancer	4.45e-06	3.5e-05	CbGpPWpGaD
Tetrahydrobiopterin—PTGS2—Metabolism—GGT1—prostate cancer	4.4e-06	3.47e-05	CbGpPWpGaD
Tetrahydrobiopterin—NOS3—Metabolism—PTEN—prostate cancer	4.37e-06	3.44e-05	CbGpPWpGaD
Tetrahydrobiopterin—NOS3—Signaling Pathways—MDM2—prostate cancer	4.34e-06	3.42e-05	CbGpPWpGaD
Tetrahydrobiopterin—PTGS2—Metabolism—NCOA1—prostate cancer	4.34e-06	3.42e-05	CbGpPWpGaD
Tetrahydrobiopterin—NOS3—Disease—MYC—prostate cancer	4.33e-06	3.42e-05	CbGpPWpGaD
Tetrahydrobiopterin—NOS3—Disease—TGFB1—prostate cancer	4.32e-06	3.41e-05	CbGpPWpGaD
Tetrahydrobiopterin—NOS3—Signaling Pathways—ERBB2—prostate cancer	4.28e-06	3.38e-05	CbGpPWpGaD
Tetrahydrobiopterin—PTGS2—Metabolism—CYP19A1—prostate cancer	4.27e-06	3.37e-05	CbGpPWpGaD
Tetrahydrobiopterin—PTGS2—Disease—LPL—prostate cancer	4.26e-06	3.36e-05	CbGpPWpGaD
Tetrahydrobiopterin—NOS3—Disease—EGFR—prostate cancer	4.24e-06	3.34e-05	CbGpPWpGaD
Tetrahydrobiopterin—NOS3—Signaling Pathways—PIK3CB—prostate cancer	4.23e-06	3.33e-05	CbGpPWpGaD
Tetrahydrobiopterin—PTGS2—Disease—PDGFRB—prostate cancer	4.22e-06	3.33e-05	CbGpPWpGaD
Tetrahydrobiopterin—NOS3—Metabolism—EP300—prostate cancer	4.17e-06	3.28e-05	CbGpPWpGaD
Tetrahydrobiopterin—PTGS2—Metabolism—RXRA—prostate cancer	4.12e-06	3.25e-05	CbGpPWpGaD
Tetrahydrobiopterin—PTGS2—Disease—ERCC2—prostate cancer	4.08e-06	3.22e-05	CbGpPWpGaD
Tetrahydrobiopterin—NOS3—Signaling Pathways—CXCL8—prostate cancer	4.06e-06	3.2e-05	CbGpPWpGaD
Tetrahydrobiopterin—PTGS2—Metabolism of lipids and lipoproteins—PTEN—prostate cancer	4.01e-06	3.16e-05	CbGpPWpGaD
Tetrahydrobiopterin—NOS3—Disease—KRAS—prostate cancer	4e-06	3.16e-05	CbGpPWpGaD
Tetrahydrobiopterin—PTGS2—Disease—ERBB3—prostate cancer	3.99e-06	3.14e-05	CbGpPWpGaD
Tetrahydrobiopterin—PTGS2—Disease—FGFR2—prostate cancer	3.98e-06	3.14e-05	CbGpPWpGaD
Tetrahydrobiopterin—PTGS2—Metabolism—COMT—prostate cancer	3.97e-06	3.13e-05	CbGpPWpGaD
Tetrahydrobiopterin—NOS3—Signaling Pathways—CDKN1B—prostate cancer	3.97e-06	3.13e-05	CbGpPWpGaD
Tetrahydrobiopterin—PTGS2—Metabolism—GSTP1—prostate cancer	3.95e-06	3.12e-05	CbGpPWpGaD
Tetrahydrobiopterin—PTGS2—Metabolism—ITPR1—prostate cancer	3.89e-06	3.07e-05	CbGpPWpGaD
Tetrahydrobiopterin—NOS3—Signaling Pathways—CASP3—prostate cancer	3.89e-06	3.06e-05	CbGpPWpGaD
Tetrahydrobiopterin—NOS3—Signaling Pathways—IL2—prostate cancer	3.88e-06	3.06e-05	CbGpPWpGaD
Tetrahydrobiopterin—PTGS2—Disease—MTHFR—prostate cancer	3.83e-06	3.02e-05	CbGpPWpGaD
Tetrahydrobiopterin—PTGS2—Metabolism of lipids and lipoproteins—EP300—prostate cancer	3.82e-06	3.02e-05	CbGpPWpGaD
Tetrahydrobiopterin—PTGS2—Disease—TERT—prostate cancer	3.82e-06	3.01e-05	CbGpPWpGaD
Tetrahydrobiopterin—NOS3—Signaling Pathways—CCND1—prostate cancer	3.78e-06	2.98e-05	CbGpPWpGaD
Tetrahydrobiopterin—NOS3—Signaling Pathways—CTNNB1—prostate cancer	3.75e-06	2.95e-05	CbGpPWpGaD
Tetrahydrobiopterin—NOS3—Disease—PIK3CA—prostate cancer	3.68e-06	2.9e-05	CbGpPWpGaD
Tetrahydrobiopterin—PTGS2—Metabolism—TYMS—prostate cancer	3.68e-06	2.9e-05	CbGpPWpGaD
Tetrahydrobiopterin—NOS3—Signaling Pathways—MMP9—prostate cancer	3.67e-06	2.9e-05	CbGpPWpGaD
Tetrahydrobiopterin—NOS3—Signaling Pathways—CDKN1A—prostate cancer	3.66e-06	2.89e-05	CbGpPWpGaD
Tetrahydrobiopterin—PTGS2—Disease—HIF1A—prostate cancer	3.66e-06	2.88e-05	CbGpPWpGaD
Tetrahydrobiopterin—NOS3—Signaling Pathways—PTEN—prostate cancer	3.65e-06	2.88e-05	CbGpPWpGaD
Tetrahydrobiopterin—PTGS2—Metabolism—GSTM1—prostate cancer	3.63e-06	2.86e-05	CbGpPWpGaD
Tetrahydrobiopterin—TH—Metabolism—AKT1—prostate cancer	3.63e-06	2.86e-05	CbGpPWpGaD
Tetrahydrobiopterin—PTGS2—Metabolism—LPL—prostate cancer	3.57e-06	2.81e-05	CbGpPWpGaD
Tetrahydrobiopterin—PTGS2—Disease—CAV1—prostate cancer	3.54e-06	2.79e-05	CbGpPWpGaD
Tetrahydrobiopterin—NOS3—Signaling Pathways—EP300—prostate cancer	3.48e-06	2.75e-05	CbGpPWpGaD
Tetrahydrobiopterin—PTGS2—Metabolism—CYP1A1—prostate cancer	3.44e-06	2.72e-05	CbGpPWpGaD
Tetrahydrobiopterin—PTGS2—Metabolism—ERCC2—prostate cancer	3.42e-06	2.69e-05	CbGpPWpGaD
Tetrahydrobiopterin—NOS3—Signaling Pathways—SRC—prostate cancer	3.39e-06	2.67e-05	CbGpPWpGaD
Tetrahydrobiopterin—PTGS2—Disease—BAD—prostate cancer	3.33e-06	2.62e-05	CbGpPWpGaD
Tetrahydrobiopterin—NOS3—Signaling Pathways—VEGFA—prostate cancer	3.3e-06	2.6e-05	CbGpPWpGaD
Tetrahydrobiopterin—NOS3—Signaling Pathways—STAT3—prostate cancer	3.27e-06	2.58e-05	CbGpPWpGaD
Tetrahydrobiopterin—NOS3—Disease—IL6—prostate cancer	3.26e-06	2.57e-05	CbGpPWpGaD
Tetrahydrobiopterin—PTGS2—Disease—APC—prostate cancer	3.22e-06	2.54e-05	CbGpPWpGaD
Tetrahydrobiopterin—PTGS2—Metabolism—MTHFR—prostate cancer	3.21e-06	2.53e-05	CbGpPWpGaD
Tetrahydrobiopterin—PTGS2—Disease—EGF—prostate cancer	3.18e-06	2.51e-05	CbGpPWpGaD
Tetrahydrobiopterin—PTGS2—Disease—IRS1—prostate cancer	3.18e-06	2.51e-05	CbGpPWpGaD
Tetrahydrobiopterin—PTGS2—Metabolism—PPARA—prostate cancer	3.15e-06	2.48e-05	CbGpPWpGaD
Tetrahydrobiopterin—PTGS2—Disease—GSK3B—prostate cancer	3.09e-06	2.44e-05	CbGpPWpGaD
Tetrahydrobiopterin—NOS3—Metabolism—PIK3CA—prostate cancer	3.08e-06	2.43e-05	CbGpPWpGaD
Tetrahydrobiopterin—PTGS2—Disease—INS—prostate cancer	3.05e-06	2.4e-05	CbGpPWpGaD
Tetrahydrobiopterin—NOS3—Signaling Pathways—MYC—prostate cancer	3.03e-06	2.39e-05	CbGpPWpGaD
Tetrahydrobiopterin—NOS3—Signaling Pathways—TGFB1—prostate cancer	3.03e-06	2.39e-05	CbGpPWpGaD
Tetrahydrobiopterin—NOS3—Disease—AKT1—prostate cancer	3.01e-06	2.37e-05	CbGpPWpGaD
Tetrahydrobiopterin—PTGS2—Disease—CREBBP—prostate cancer	2.99e-06	2.35e-05	CbGpPWpGaD
Tetrahydrobiopterin—NOS3—Signaling Pathways—EGFR—prostate cancer	2.97e-06	2.34e-05	CbGpPWpGaD
Tetrahydrobiopterin—PTGS2—Metabolism—CAV1—prostate cancer	2.96e-06	2.33e-05	CbGpPWpGaD
Tetrahydrobiopterin—PTGS2—Disease—MAP2K1—prostate cancer	2.85e-06	2.25e-05	CbGpPWpGaD
Tetrahydrobiopterin—PTGS2—Disease—PIK3CD—prostate cancer	2.83e-06	2.23e-05	CbGpPWpGaD
Tetrahydrobiopterin—PTGS2—Metabolism of lipids and lipoproteins—PIK3CA—prostate cancer	2.83e-06	2.23e-05	CbGpPWpGaD
Tetrahydrobiopterin—NOS3—Signaling Pathways—KRAS—prostate cancer	2.8e-06	2.21e-05	CbGpPWpGaD
Tetrahydrobiopterin—PTGS2—Disease—SERPINE1—prostate cancer	2.8e-06	2.21e-05	CbGpPWpGaD
Tetrahydrobiopterin—PTGS2—Disease—FGF2—prostate cancer	2.71e-06	2.14e-05	CbGpPWpGaD
Tetrahydrobiopterin—PTGS2—Metabolism—PIK3CG—prostate cancer	2.7e-06	2.13e-05	CbGpPWpGaD
Tetrahydrobiopterin—PTGS2—Disease—NOS3—prostate cancer	2.67e-06	2.11e-05	CbGpPWpGaD
Tetrahydrobiopterin—PTGS2—Disease—JAK2—prostate cancer	2.6e-06	2.05e-05	CbGpPWpGaD
Tetrahydrobiopterin—NOS3—Signaling Pathways—PIK3CA—prostate cancer	2.58e-06	2.03e-05	CbGpPWpGaD
Tetrahydrobiopterin—PTGS2—Metabolism—INS—prostate cancer	2.55e-06	2.01e-05	CbGpPWpGaD
Tetrahydrobiopterin—PTGS2—Disease—MDM2—prostate cancer	2.54e-06	2e-05	CbGpPWpGaD
Tetrahydrobiopterin—NOS3—Metabolism—AKT1—prostate cancer	2.52e-06	1.98e-05	CbGpPWpGaD
Tetrahydrobiopterin—PTGS2—Metabolism—CREBBP—prostate cancer	2.5e-06	1.97e-05	CbGpPWpGaD
Tetrahydrobiopterin—PTGS2—Disease—ERBB2—prostate cancer	2.5e-06	1.97e-05	CbGpPWpGaD
Tetrahydrobiopterin—NOS3—Signaling Pathways—TP53—prostate cancer	2.49e-06	1.97e-05	CbGpPWpGaD
Tetrahydrobiopterin—PTGS2—Disease—PIK3CB—prostate cancer	2.47e-06	1.95e-05	CbGpPWpGaD
Tetrahydrobiopterin—PTGS2—Metabolism—PIK3CD—prostate cancer	2.37e-06	1.87e-05	CbGpPWpGaD
Tetrahydrobiopterin—PTGS2—Disease—CDKN1B—prostate cancer	2.32e-06	1.83e-05	CbGpPWpGaD
Tetrahydrobiopterin—NOS3—Signaling Pathways—IL6—prostate cancer	2.28e-06	1.8e-05	CbGpPWpGaD
Tetrahydrobiopterin—PTGS2—Metabolism—NOS3—prostate cancer	2.24e-06	1.77e-05	CbGpPWpGaD
Tetrahydrobiopterin—PTGS2—Disease—CTNNB1—prostate cancer	2.19e-06	1.73e-05	CbGpPWpGaD
Tetrahydrobiopterin—PTGS2—Disease—CDKN1A—prostate cancer	2.14e-06	1.69e-05	CbGpPWpGaD
Tetrahydrobiopterin—PTGS2—Disease—PTEN—prostate cancer	2.13e-06	1.68e-05	CbGpPWpGaD
Tetrahydrobiopterin—NOS3—Signaling Pathways—AKT1—prostate cancer	2.1e-06	1.66e-05	CbGpPWpGaD
Tetrahydrobiopterin—PTGS2—Metabolism—PIK3CB—prostate cancer	2.07e-06	1.63e-05	CbGpPWpGaD
Tetrahydrobiopterin—PTGS2—Disease—EP300—prostate cancer	2.03e-06	1.6e-05	CbGpPWpGaD
Tetrahydrobiopterin—PTGS2—Disease—SRC—prostate cancer	1.98e-06	1.56e-05	CbGpPWpGaD
Tetrahydrobiopterin—PTGS2—Disease—STAT3—prostate cancer	1.91e-06	1.5e-05	CbGpPWpGaD
Tetrahydrobiopterin—PTGS2—Metabolism—PTEN—prostate cancer	1.79e-06	1.41e-05	CbGpPWpGaD
Tetrahydrobiopterin—PTGS2—Disease—MYC—prostate cancer	1.77e-06	1.4e-05	CbGpPWpGaD
Tetrahydrobiopterin—PTGS2—Disease—TGFB1—prostate cancer	1.77e-06	1.39e-05	CbGpPWpGaD
Tetrahydrobiopterin—PTGS2—Disease—EGFR—prostate cancer	1.73e-06	1.37e-05	CbGpPWpGaD
Tetrahydrobiopterin—PTGS2—Metabolism—EP300—prostate cancer	1.7e-06	1.34e-05	CbGpPWpGaD
Tetrahydrobiopterin—PTGS2—Disease—KRAS—prostate cancer	1.64e-06	1.29e-05	CbGpPWpGaD
Tetrahydrobiopterin—PTGS2—Disease—PIK3CA—prostate cancer	1.5e-06	1.19e-05	CbGpPWpGaD
Tetrahydrobiopterin—PTGS2—Disease—IL6—prostate cancer	1.33e-06	1.05e-05	CbGpPWpGaD
Tetrahydrobiopterin—PTGS2—Metabolism—PIK3CA—prostate cancer	1.26e-06	9.93e-06	CbGpPWpGaD
Tetrahydrobiopterin—PTGS2—Disease—AKT1—prostate cancer	1.23e-06	9.69e-06	CbGpPWpGaD
Tetrahydrobiopterin—PTGS2—Metabolism—AKT1—prostate cancer	1.03e-06	8.12e-06	CbGpPWpGaD
